Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Optic Nerve Injuries | 2 | 2014 | 13 | 0.480 |
Why?
|
| Salivary Glands, Minor | 1 | 2015 | 11 | 0.470 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2015 | 67 | 0.450 |
Why?
|
| Methylprednisolone | 1 | 2014 | 104 | 0.430 |
Why?
|
| Decompression, Surgical | 1 | 2014 | 91 | 0.430 |
Why?
|
| Optic Nerve | 2 | 2014 | 116 | 0.410 |
Why?
|
| Endoscopy | 2 | 2014 | 291 | 0.410 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 1065 | 0.320 |
Why?
|
| Visual Acuity | 1 | 2014 | 845 | 0.310 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2019 | 875 | 0.310 |
Why?
|
| Deglutition Disorders | 2 | 2019 | 146 | 0.270 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2019 | 283 | 0.250 |
Why?
|
| Gastrostomy | 2 | 2019 | 91 | 0.190 |
Why?
|
| Graves Ophthalmopathy | 1 | 2021 | 14 | 0.180 |
Why?
|
| Neuralgia | 1 | 2021 | 54 | 0.170 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 1402 | 0.160 |
Why?
|
| Laryngeal Neoplasms | 1 | 2019 | 104 | 0.150 |
Why?
|
| Parathyroid Neoplasms | 1 | 1997 | 23 | 0.140 |
Why?
|
| Hyperparathyroidism | 1 | 1997 | 27 | 0.140 |
Why?
|
| Adenoma | 1 | 1997 | 138 | 0.130 |
Why?
|
| Disease Management | 1 | 2019 | 559 | 0.120 |
Why?
|
| Ethmoid Bone | 1 | 2015 | 9 | 0.120 |
Why?
|
| Maxilla | 1 | 2015 | 38 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 471 | 0.110 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 169 | 0.110 |
Why?
|
| Recurrence | 3 | 2014 | 1469 | 0.110 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 254 | 0.110 |
Why?
|
| Diagnostic Imaging | 2 | 2015 | 312 | 0.110 |
Why?
|
| Laryngeal Diseases | 2 | 2004 | 32 | 0.110 |
Why?
|
| Middle Aged | 12 | 2019 | 29347 | 0.110 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 402 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 664 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2014 | 408 | 0.090 |
Why?
|
| Veterans | 2 | 2019 | 1768 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1731 | 0.080 |
Why?
|
| Nose Neoplasms | 1 | 1990 | 33 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 5491 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2019 | 3683 | 0.080 |
Why?
|
| Neurilemmoma | 1 | 1990 | 48 | 0.080 |
Why?
|
| Zenker Diverticulum | 1 | 2008 | 4 | 0.080 |
Why?
|
| Orbit | 2 | 2021 | 103 | 0.070 |
Why?
|
| Skull Neoplasms | 1 | 1988 | 16 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 1312 | 0.070 |
Why?
|
| Mandibular Diseases | 1 | 1987 | 10 | 0.070 |
Why?
|
| Male | 13 | 2019 | 65774 | 0.070 |
Why?
|
| Esophagoscopy | 1 | 2008 | 164 | 0.070 |
Why?
|
| Retrospective Studies | 6 | 2021 | 17436 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 2 | 2002 | 693 | 0.060 |
Why?
|
| Humans | 18 | 2021 | 133540 | 0.060 |
Why?
|
| Aged | 8 | 2019 | 21701 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 1988 | 248 | 0.060 |
Why?
|
| Female | 13 | 2019 | 71524 | 0.060 |
Why?
|
| Osteomyelitis | 1 | 1987 | 212 | 0.060 |
Why?
|
| Laryngectomy | 1 | 2004 | 34 | 0.060 |
Why?
|
| Aspergillosis | 1 | 2004 | 47 | 0.060 |
Why?
|
| Time Factors | 2 | 2014 | 6579 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 1987 | 325 | 0.060 |
Why?
|
| Abscess | 1 | 2004 | 141 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2019 | 1314 | 0.050 |
Why?
|
| Xerostomia | 1 | 2002 | 12 | 0.050 |
Why?
|
| Pharyngeal Diseases | 1 | 2003 | 20 | 0.050 |
Why?
|
| Radiotherapy, Conformal | 1 | 2002 | 63 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2014 | 13001 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2004 | 304 | 0.050 |
Why?
|
| Anti-Ulcer Agents | 1 | 2003 | 116 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2003 | 132 | 0.050 |
Why?
|
| Radiation Injuries | 1 | 2002 | 162 | 0.050 |
Why?
|
| Laryngoscopy | 1 | 2003 | 157 | 0.040 |
Why?
|
| Glottis | 1 | 2019 | 31 | 0.040 |
Why?
|
| Deglutition | 1 | 2019 | 59 | 0.040 |
Why?
|
| Sinusitis | 1 | 2000 | 119 | 0.040 |
Why?
|
| Morbidity | 1 | 2019 | 255 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2000 | 2219 | 0.040 |
Why?
|
| Adult | 5 | 2014 | 31933 | 0.040 |
Why?
|
| Sphenoid Bone | 1 | 1997 | 10 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 972 | 0.030 |
Why?
|
| Cysts | 1 | 1997 | 108 | 0.030 |
Why?
|
| Nose | 1 | 1997 | 98 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2008 | 7202 | 0.030 |
Why?
|
| Prognosis | 3 | 2019 | 5064 | 0.030 |
Why?
|
| Conjunctiva | 1 | 1997 | 198 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 2202 | 0.030 |
Why?
|
| United States | 2 | 2019 | 11656 | 0.030 |
Why?
|
| Diet | 1 | 2019 | 1197 | 0.020 |
Why?
|
| Incidence | 1 | 2019 | 3386 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2000 | 1848 | 0.020 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 1990 | 18 | 0.020 |
Why?
|
| Risk Factors | 2 | 2019 | 11056 | 0.020 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1989 | 12 | 0.020 |
Why?
|
| Nasal Cavity | 1 | 1990 | 53 | 0.020 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1989 | 62 | 0.020 |
Why?
|
| Esophageal Sphincter, Upper | 1 | 2008 | 5 | 0.020 |
Why?
|
| Propionibacterium acnes | 1 | 1987 | 13 | 0.020 |
Why?
|
| Angiography | 1 | 1988 | 214 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 1988 | 114 | 0.020 |
Why?
|
| Mandible | 1 | 1987 | 82 | 0.020 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2004 | 23 | 0.010 |
Why?
|
| Whole-Body Irradiation | 1 | 2004 | 61 | 0.010 |
Why?
|
| Reoperation | 1 | 2008 | 866 | 0.010 |
Why?
|
| Parotid Gland | 1 | 2002 | 21 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 2008 | 3208 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 335 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2002 | 226 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2004 | 309 | 0.010 |
Why?
|
| Observer Variation | 1 | 2003 | 312 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 454 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2004 | 621 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1990 | 3839 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 747 | 0.010 |
Why?
|
| Nasal Polyps | 1 | 2000 | 25 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 690 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2003 | 6654 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 2003 | 337 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 2165 | 0.010 |
Why?
|
| Sphenoid Sinus | 1 | 1997 | 12 | 0.010 |
Why?
|
| Turbinates | 1 | 1997 | 13 | 0.010 |
Why?
|
| Endoscopes | 1 | 1997 | 20 | 0.010 |
Why?
|
| Nerve Compression Syndromes | 1 | 1997 | 22 | 0.010 |
Why?
|
| Electrocoagulation | 1 | 1997 | 35 | 0.010 |
Why?
|
| Skull Fractures | 1 | 1997 | 44 | 0.010 |
Why?
|
| Craniotomy | 1 | 1997 | 109 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 1997 | 157 | 0.010 |
Why?
|
| Optic Nerve Diseases | 1 | 1997 | 88 | 0.010 |
Why?
|
| Adolescent | 3 | 2004 | 20514 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2000 | 1250 | 0.010 |
Why?
|
| Lacrimal Apparatus | 1 | 1997 | 128 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 3631 | 0.010 |
Why?
|
| Vision Disorders | 1 | 1997 | 220 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1997 | 339 | 0.010 |
Why?
|
| Quality of Life | 1 | 2002 | 2130 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2002 | 3992 | 0.010 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1989 | 55 | 0.010 |
Why?
|
| Child | 1 | 1989 | 25711 | 0.000 |
Why?
|